InsidersTradesSigma
Follow the 제이피아이헬스케어 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 제이피아이헬스케어 has logged 8 insider filings. Market capitalisation: €44.5bn. The latest transaction was filed on 15 July 2026 (Purchase). Among the most active insiders: 이승혜. The full history is accessible without an account.
7
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,077 of 29,063 companies
70.6
score / 100
Value77
Quality65
FCF yld4.5%
Earn yld12%
EV/EBITDA7.5x
ROE13%
Gross mgn42%
Net mgn11%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 July 2026
Declarations8 total
Other
1,558,000 sharesKRXDART:20250826000269
1,558,000 sharesShareKRXDART:20250826000265
8 of 8 declarations
Acerca de 제이피아이헬스케어
제이피아이헬스케어 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se especializa en el desarrollo y suministro de soluciones de salud innovadoras.